Dysregulated Expression of Myeloid Nuclear Differentiation Antigen (MNDA) in MDS: Possible Role in TRAIL-Induced Apoptosis.
Robert C. Briggs(Vanderbilt University), David R. Head(University of Southern California), James W. Jacobberger(University Hospitals Cleveland Medical Center), Stacey Goodman(Texas Oncology), Sara A. McClintock-Treep(Vanderbilt University), Leanne A. Flye(Center for Innovation), Madan Jagasia(Vanderbilt University Medical Center), Fouad Boulos(Vanderbilt University), Keith Shults(Center for Innovation), Greg Stelzer(Center for Innovation)
Cited by 0
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Age and acute myeloid leukemia
|Blood|2006|1.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k